Prosecution Insights
Last updated: April 19, 2026
Application No. 16/702,901

PACKAGING MATERIAL AND AN ORAL POUCHED NICOTINE PRODUCT

Non-Final OA §103
Filed
Dec 04, 2019
Examiner
NGUYEN, PHU HOANG
Art Unit
1747
Tech Center
1700 — Chemical & Materials Engineering
Assignee
Swedish Match North Europe AB
OA Round
7 (Non-Final)
65%
Grant Probability
Favorable
7-8
OA Rounds
3y 10m
To Grant
84%
With Interview

Examiner Intelligence

Grants 65% — above average
65%
Career Allow Rate
450 granted / 691 resolved
At TC average
Strong +19% interview lift
Without
With
+18.7%
Interview Lift
resolved cases with interview
Typical timeline
3y 10m
Avg Prosecution
56 currently pending
Career history
747
Total Applications
across all art units

Statute-Specific Performance

§101
0.1%
-39.9% vs TC avg
§103
51.3%
+11.3% vs TC avg
§102
14.1%
-25.9% vs TC avg
§112
18.1%
-21.9% vs TC avg
Black line = Tech Center average estimate • Based on career data from 691 resolved cases

Office Action

§103
Notice of Pre-AIA or AIA Status The present application, filed on or after March 16, 2013, is being examined under the first inventor to file provisions of the AIA . Claim Rejections - 35 USC § 103 The following is a quotation of 35 U.S.C. 103 which forms the basis for all obviousness rejections set forth in this Office action: A patent for a claimed invention may not be obtained, notwithstanding that the claimed invention is not identically disclosed as set forth in section 102, if the differences between the claimed invention and the prior art are such that the claimed invention as a whole would have been obvious before the effective filing date of the claimed invention to a person having ordinary skill in the art to which the claimed invention pertains. Patentability shall not be negated by the manner in which the invention was made. Claims 1-14, 16, 19-20 and 22-26 is/are rejected under 35 U.S.C. 103 as being unpatentable over Sebastian et al. (U.S 20160073689) in view of Mitchell et al. (U.S Pub. No. 20100272938). Regarding claims 1 and 24, Sebastian et al. discloses a packaging material for use in an oral pouched nicotine product in order to enclose a filing material ({0001], pouched product), said filling material comprising a particulate non-tobacco material and a nicotine source ([0009], lines 12-14), said packaging material being a saliva-permeable ([0009], lines 3-4, outer water- permeable pouch) nonwoven material ([0010], lines 1-2, nonwoven web) comprising carded fibres ((0011], line 2), wherein: 50%-100% ([0050], lines 14-18, 1:2 ratio of binder to other fiber types indicates about 67% of other fiber types) of said carded fibres are cellulose-based staple fibres ({0017], lines 3-7; [0043], lines 13-16; cellulosic staple fibers such as rayon as the other fiber type), 0%-50% ([0050], lines 14-18, 1:2 ratio of binder to other fiber types indicated about 33% of binder fibers) of said carded fibres are thermoplastic fibres ([0044], lines 2-5, binder fibers as multicomponent fibers comprising thermoplastic fibers; [0045], lines 12-13, polylactic acid or PLA). While the reference does not specifically disclose the measurement conditions for the thermoplastic fibres (21°C and 50% RH), given the ranges taught by the prior art, the thermoplastic fibres would clearly fall within the claimed range under the conditions cited in the claim. Sebastian et al. further discloses that said packaging material further comprises a binder ((0044], lines 2-5, second polymer material of the multicomponent fibers), said binder constituting 20%-60% of a total weight of said packaging material ([0050], lines 14-18, 1:2 ratio of binder to other fiber types indicated about 33% of binder fibers), and said cellulose-based staple fibres have a linear density less than 1.7 decitex ([0077], line 1, rayon fibers with 1.5 dtex). Sebastian et al. teaches that said packaging material has a basis weight of about 20 gsm to about 35 gsm ([0059], lines 8-9,) which overlaps with the claimed range of above 30 g/m?. It is well settled that where the prior art describes the components of a claimed compound or compositions in concentrations within or overlapping the claimed concentrations, a prima facie case of obviousness is established. See In re Harris, 409 F. 3d 1339, 1343, 74 USPQ2d 1951, 1953 (Fed. Cir 2005); In re Peterson, 315 F.3d 1325, 1329, 65 USPQ 2d 1379, 1382 (Fed. Cir. 1997); In re Woodruff, 919 F.2d 1575, 1578 16 USPQ2d 1934, 1936-37 (CCPA 1990); In re Malagari, 499 F.2d 1297, 1303, 182 USPQ 549, 553 (CCPA 1974). Sebastian discloses the binder comprises an adhesive but does not expressly disclose the adhesive is an emulsion. Mitchell discloses binding material for nonwoven sheet includes adhesive such as polyvinyl acetate [0054]. Therefore, it would have been obvious to one of ordinary skill in the art at the time the invention was made to use polyvinyl acetate as taught by Mitchell as the adhesive in the packaging material of Sebastian. Mitchell discloses the binder (polyvinyl acetate corresponding to the claimed an emulsion formed by polymerization of vinyl acetate (not being the thermoplastic fibres)) constituting about 5% to 30% of the packaging material [0054] overlapping with the claimed range. In case of overlapping ranges, it would have been obvious to one of ordinary skill in the art at the time the invention was made to pick the claimed range. Regarding claim 2, Sebastian et al. discloses the packaging material wherein 55%-99% of said carded fibres are cellulose-based staple fibres ([0050], lines 14-18, 1:2 ratio of binder to other fiber types indicates about 67% of other fiber types; [0017], lines 3-7, cellulosic staple fibers as the other fiber type). Regarding claim 3, Sebastian et al. discloses the packaging material wherein 1%-45% of said carded fibres are thermoplastic fibres ([0050], lines 14-18, 1:2 ratio of binder to other fiber types indicated about 33% of binder fibers; [0044], lines 2-5, binder fibers as multicomponent fibers comprising thermoplastic fibers; [0045], lines 12-13, polylactic acid or PLA). Regarding claim 4, Sebastian et al. discloses the packaging material wherein said carded fibres consist of said cellulose-based staples fibres and said thermoplastic fibres ([0077], lines 1- 4). Regarding claim 5, Sebastian et al. discloses the packaging material wherein said packaging material consists of said cellulose-based staple fibres, said thermoplastic fibres and said binder ({0043], lines 13-16; [0044], lines 2-5). Regarding claim 6, Sebastian et al. teaches the packaging material wherein said basis weight of said packaging material is > 32 g/m? ([0059], lines 8-9, about 20 gsm to about 35 gsm). Even though Sebastian et al. lists an example with a basis weight of about 30 gsm ([0082], lines 6-7), which does not overlap with the claimed range of > 32 g/m”, Sebastian et al. teaches a basis weight range of about 20 gsm to about 35 gsm. It is well settled that where the prior art describes the components of a claimed compound or compositions in concentrations within or overlapping the claimed concentrations, a prima facie case of obviousness is established. See In re Harris, 409 F. 3d 1339, 1343, 74 USPQ2d 1951, 1953 (Fed. Cir 2005); In re Peterson, 315 F.3d 1325, 1329, 65 USPQ 2d 1379, 1382 (Fed. Cir. 1997); In re Woodruff, 919 F.2d 1575, 1578 16 USPQ2d 1934, 1936-37 (CCPA 1990); In re Malagari, 499 F.2d 1297, 1303, 182 USPQ 549, 553 (CCPA 1974). Regarding claim 7, Sebastian et al. discloses the packaging material wherein said cellulose-based staple fibres are natural cellulose fibres or man-made cellulose-based fibres ({0043], lines 14-15, regenerated cellulose rayon). Regarding claim 8, Sebastian et al. discloses the packaging material wherein said cellulose-based staple fibres have a linear density of < 1.5 decitex ({0077], line 1, rayon fibers with 1.5 dtex). Regarding claim 9, Sebastian et al. discloses the packaging material wherein said cellulose-based staple fibres have a length within the range of 30-80 mm ([0052], lines 10-12). Regarding claim 10, Sebastian et al. discloses the packaging material wherein said thermoplastic fibres comprise of one or more of PP, PLA, PET, PP/PE, or PLA/co-PLA ([0045], lines 12-13, polylactic acid or PLA). Regarding claim 11, Sebastian et al. discloses the packaging material wherein said thermoplastic fibres have a length within the range of 30-80 mm ([0052], lines 10-12). Regarding claim 12, Sebastian et al. discloses the packaging material wherein said thermoplastic fibres have a linear density of < 4.4 decitex ((0077], line 1, PLA fibers with 1.5 dtex). Regarding claim 13, Sebastian et al. discloses the packaging material wherein said thermoplastic fibres have a melting point within the range of 110-260°C ([0045], lines 6-8, about 150°C). Regarding claim 14, Sebastian et al. discloses the packaging material wherein said binder constitutes 25%-55% of a total weight of said packaging material ({0050], lines 14-18, 1:2 ratio of binder to other fiber types indicated about 33% of binder fibers). Regarding claim 16, Sebastian et al. teaches the packaging material wherein said packaging material has an air permeability of greater than about 10,000 ml/min/cm? ([0059], lines 25-26, greater than approximately 1,667 1/m7/s) overlapping with the claimed range of < 4,000 I/m7/s. It is well settled that where the prior art describes the components of a claimed compound or compositions in concentrations within or overlapping the claimed concentrations, a prima facie case of obviousness is established. See In re Harris, 409 F. 3d 1339, 1343, 74 USPQ2d 1951, 1953 (Fed. Cir 2005); In re Peterson, 315 F.3d 1325, 1329, 65 USPQ 2d 1379, 1382 (Fed. Cir. 1997); In re Woodruff, 919 F.2d 1575, 1578 16 USPQ2d 1934, 1936-37 (CCPA 1990); In re Malagari, 499 F.2d 1297, 1303, 182 USPQ 549, 553 (CCPA 1974). Regarding claim 19, Sebastian et al. discloses an oral pouched nicotine product [0001], said product comprising a filling material ([0009], lines 4-6, composition comprising a water- soluble component) and a saliva-permeable pouch ((0009], lines 3-4, outer water-permeable pouch), said filling material comprising a particulate non-tobacco material and a nicotine source ([009], lines 12-14), said pouch enclosing said portion ({0010], lines 8-11; Fig. 1), said pouch comprising the packaging material of claim 1, wherein said packaging material is sealed with at least one seal to enclose said portion ([0018], lines 17-19; Fig. 1), and wherein said binder constitutes 20%-60% of a total weight of said packaging material ([0050], lines 14-18, 1:2 ratio of binder to other fiber types indicated about 33% of binder fibers). Regarding claim 20, Sebastian et al. discloses the packaging material wherein said thermoplastic fibres are at least partially melted ({0043], lines 5-9; [0057], lines 6-8). Regarding claim 22, the binder of Sebastian is configured for chemical bonding (not hydro-entanglement of said packaging material [0050]. Regarding claims 25-26, in additions to the features discussed above for claim 1, Sebastian also discloses the regenerated cellulose fibers can be rayon or viscose fibers [0043], viscose fibers have a linear density overlapping with the claimed range of less than 1.3 decitex. Therefore, it would have been obvious to one of ordinary skill in the art at the time the invention was made to pick the claimed range. Claim 15 is rejected under 35 U.S.C. 103 as being unpatentable over Sebastian et al. (U.S. 2016/0073689 A1) in view of Mitchell et al. (U.S Pub. No. 20100272938) as applied to claim 1 above and further in view of Persson (EP 3 330 191 A1). Regarding claim 15, Sebastian et al. discloses all the claim limitations as set forth above. Sebastian et al. also discloses using ultrasonic bonding to strengthen the pouch seal ([0057], lines 9-13). However, the reference does not explicitly disclose the packaging material having a dry seal strength of at least 0.2 N/mm when said seal is made by ultrasonic welding. Persson teaches a similar packaging material [0001] wherein said packaging material has a dry seal strength of at least 0.2 N/mm ((0029], lines 30-31, at least 0.2 N/mm in dry state) when said seal is made by ultrasonic welding ([0020], lines 37-40; [0115], lines 57-58). Therefore, it would have been obvious to one of ordinary skill in the art at the time the invention was filed to have modified the product of Sebastian et al. to specify a dry seal strength of at least 0.2 N/mm as taught by Persson to improve the quality of the packaging material product. A higher dry seal strength will reduce the possibility of a seal breaking during both the shipment and the use of the product. Claims 17, 18, and 21 are rejected under 35 U.S.C. 103 as being unpatentable over Sebastian et al. (U.S. 2016/0073689 A1) in view of Mitchell et al. (U.S Pub. No. 20100272938) as applied to claim 1 above and further in view of Irie et al. (U.S. 2010/0189936 A1). Regarding claims 17, 18, and 21, Sebastian et al. discloses all the claimed limitations as set forth above but does not explicitly disclose that the packaging material has a median pore size of < 300 um? and a powder leakage of < 400 mg, or that the oral pouched nicotine product has a powder leakage of < 100 mg. Irie et al. teaches a similar packaging material (abstract; [0039], lines 5-9, low fabric weight preferred; [0063], bag shape, heat sealed; [0065], bags containing a packed material; [0142], lines 1-6, packaging materials) wherein said packaging material has a median pore size of < 300 um? ((0071], lines 1-4, 50 um or less). Irie et al. specifically teaches that the maximum pore size should preferably be between 3 and 30 um because nonwoven fabrics need to have both an excellent filtering function and an excellent barrier function ((0071], lines 4-7). Irie et al. further teaches that the packaging material has a powder leakage of < 400 mg (Page 8, Table 2, Ex. 2 has a powder leakage of 0.1%) and that the oral pouched nicotine product has a powder leakage of < 100 mg (Page 8, Table 2, Ex. 2 has a powder leakage of 0.1%). While Irie et al. does not explicitly teach an oral pouched nicotine product, it does teach that possible applications of the nonwoven fabric include making tea filters and bags ((0142], the likes). Additionally, the inclusion of tea filters and bags for seasoning indicates that the nonwoven fabric can be used for items intended for human consumption such as oral pouched nicotine products. Therefore, it would have been obvious to one of ordinary skill in the art at the time the invention was filed to have modified the product of Sebastian et al. to specify a median pore size of < 300 um? and a powder leakage of < 400 mg or more specifically < 100 mg for oral pouched nicotine products as taught by Irie et al. as a way to improve the quality of the packaging material product. Since the average particle size of a powder filling material would be very small, it is necessary that a sufficiently small median pore size is selected to minimize the powder leakage of the packaging material. Reducing the powder leakage will then reduce the amount of filling material lost during both the shipment and the use of the packaging material product. For specifically an oral pouched nicotine product, a loss of the filling material during shipment can negatively impact the amount of time a user can use the product, and a loss of the filling material during use would result in loose powder entering a user’s mouth. Response to Arguments Applicant’s arguments filed 7/28/2025 have been considered but are moot in view of the new ground of rejection. Conclusion Any inquiry concerning this communication or earlier communications from the examiner should be directed to PHU H NGUYEN whose telephone number is (571)272-5931. The examiner can normally be reached M-F 9-5. Examiner interviews are available via telephone, in-person, and video conferencing using a USPTO supplied web-based collaboration tool. To schedule an interview, applicant is encouraged to use the USPTO Automated Interview Request (AIR) at http://www.uspto.gov/interviewpractice. If attempts to reach the examiner by telephone are unsuccessful, the examiner’s supervisor, Michael H Wilson can be reached at 5712703882. The fax phone number for the organization where this application or proceeding is assigned is 571-273-8300. Information regarding the status of published or unpublished applications may be obtained from Patent Center. Unpublished application information in Patent Center is available to registered users. To file and manage patent submissions in Patent Center, visit: https://patentcenter.uspto.gov. Visit https://www.uspto.gov/patents/apply/patent-center for more information about Patent Center and https://www.uspto.gov/patents/docx for information about filing in DOCX format. For additional questions, contact the Electronic Business Center (EBC) at 866-217-9197 (toll-free). If you would like assistance from a USPTO Customer Service Representative, call 800-786-9199 (IN USA OR CANADA) or 571-272-1000. /PHU H NGUYEN/Examiner, Art Unit 1747
Read full office action

Prosecution Timeline

Dec 04, 2019
Application Filed
Feb 08, 2022
Non-Final Rejection — §103
Jun 15, 2022
Response Filed
Oct 15, 2022
Non-Final Rejection — §103
Mar 28, 2023
Applicant Interview (Telephonic)
Mar 28, 2023
Final Rejection — §103
Jul 12, 2023
Interview Requested
Sep 19, 2023
Applicant Interview (Telephonic)
Sep 19, 2023
Examiner Interview Summary
Sep 27, 2023
Request for Continued Examination
Sep 29, 2023
Response after Non-Final Action
Jan 13, 2024
Non-Final Rejection — §103
May 14, 2024
Interview Requested
May 22, 2024
Applicant Interview (Telephonic)
Jun 24, 2024
Response Filed
Aug 07, 2024
Examiner Interview Summary
Sep 30, 2024
Final Rejection — §103
Dec 18, 2024
Request for Continued Examination
Dec 19, 2024
Response after Non-Final Action
May 03, 2025
Non-Final Rejection — §103
Jul 28, 2025
Response after Non-Final Action
Jul 28, 2025
Notice of Allowance
Sep 18, 2025
Examiner Interview Summary
Sep 18, 2025
Applicant Interview (Telephonic)
Sep 24, 2025
Response after Non-Final Action
Jan 08, 2026
Non-Final Rejection — §103 (current)

Precedent Cases

Applications granted by this same examiner with similar technology

Patent 12569432
AEROSOL GENERATOR
2y 5m to grant Granted Mar 10, 2026
Patent 12569003
PRE-ROLL FILLING SYSTEM
2y 5m to grant Granted Mar 10, 2026
Patent 12557846
ELECTRONIC VAPOUR PROVISION SYSTEM
2y 5m to grant Granted Feb 24, 2026
Patent 12543775
METHODS FOR REDUCING ONE OR MORE TOBACCO SPECIFIC NITROSAMINES IN TOBACCO MATERIAL
2y 5m to grant Granted Feb 10, 2026
Patent 12532911
SMOKING ARTICLE WITH FRONT-PLUG AND METHOD
2y 5m to grant Granted Jan 27, 2026
Study what changed to get past this examiner. Based on 5 most recent grants.

AI Strategy Recommendation

Get an AI-powered prosecution strategy using examiner precedents, rejection analysis, and claim mapping.
Powered by AI — typically takes 5-10 seconds

Prosecution Projections

7-8
Expected OA Rounds
65%
Grant Probability
84%
With Interview (+18.7%)
3y 10m
Median Time to Grant
High
PTA Risk
Based on 691 resolved cases by this examiner. Grant probability derived from career allow rate.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month